Frederic Chereau is the founder of LogicBio Therapeutics. LogicBio Therapeutics has raised $50M in total funding. Based in Cambridge, MA.
Frederic Chereau is the Co-founder, President, and CEO of LogicBio Therapeutics, a genome editing company focused on developing treatments for rare pediatric diseases. He led the company from its emergence from stealth mode in 2017 through its $50 million financing round and subsequent acquisition by Alexion, AstraZeneca Rare Disease in November 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide